Organovo Holdings Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | 2.8yrs |
| Board average tenure | 4.3yrs |
Recent management updates
Recent updates
Is Organovo Holdings (NASDAQ:ONVO) In A Good Position To Invest In Growth?
Feb 10
Here's Why We're Not Too Worried About Organovo Holdings' (NASDAQ:ONVO) Cash Burn Situation
Aug 24We're Hopeful That Organovo Holdings (NASDAQ:ONVO) Will Use Its Cash Wisely
May 10We're Hopeful That Organovo Holdings (NASDAQ:ONVO) Will Use Its Cash Wisely
Jan 04Organovo: New Strategy Targeting Internal Pipeline Development With Customized 3D Human Tissues Offers Upside
May 28CEO
Organovo Holdings has no CEO, or we have no data on them.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman & Corporate Secretary | 4.5yrs | US$789.99k | 0.80% $ 53.0k | |
| Director of Discovery Biology & Director | 2.8yrs | US$119.05k | 0.26% $ 16.9k | |
| President | less than a year | no data | no data | |
| Senior Vice President of Strategy & Business Development | 2.9yrs | no data | no data |
2.8yrs
Average Tenure
52yo
Average Age
Experienced Management: ONVO's management team is considered experienced (2.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman & Corporate Secretary | 4.5yrs | US$789.99k | 0.80% $ 53.0k | |
| Director of Discovery Biology & Director | 2.8yrs | US$119.05k | 0.26% $ 16.9k | |
| Independent Director | 4.5yrs | US$124.15k | 0.26% $ 16.9k | |
| Independent Director | 4.3yrs | US$132.25k | 0.26% $ 16.9k | |
| Lead Independent Director | 4.3yrs | US$132.25k | 0.33% $ 22.1k | |
| Independent Director | 4.3yrs | US$132.25k | 0.13% $ 8.5k |
4.3yrs
Average Tenure
52.5yo
Average Age
Experienced Board: ONVO's board of directors are considered experienced (4.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 12:21 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Organovo Holdings, Inc. is covered by 9 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Sean Lavin | BTIG |
| Caroline Corner | Cantor Fitzgerald & Co. |
| Ross Muken | Evercore ISI |